Table 3 Correlation between high or low TMEM180 expression and clinicopathological features
Low, n = 92 (%) | High, n = 65 (%) | p | |
|---|---|---|---|
Age, years | |||
≤ 65 | 59 (64.1) | 41 (63.1) | 0.892 |
> 65 | 33 (35.9) | 24 (36.9) | |
Gender | |||
Female | 35 (38.0) | 36 (55.4) | 0.032 |
Male | 57 (62.0) | 29 (44.6) | |
Location | |||
Colon | 48 (52.2) | 35 (53.8) | 0.836 |
Rectum | 44 (47.8) | 30 (46.2) | |
Preoperative CEA level | |||
≤ 5 ng/ml | 55 (59.8) | 34 (52.3) | 0.352 |
> 5 ng/ml | 37 (40.2) | 31 (47.7) | |
Tumour size | |||
≤ 5 cm | 39 (42.4) | 23 (35.4) | 0.376 |
> 5 cm | 53 (57.6) | 42 (64.6) | |
Histological type | |||
Well- or moderately differentiated | 89 (96.7) | 61 (93.8) | 0.314 |
Poorly differentiated | 3 (3.3) | 4 (6.2) | |
Tumour invasion | |||
< T3 | 15 (16.3) | 12 (18.5) | 0.724 |
T3≤ | 77 (83.7) | 53 (81.5) | |
Lymph node status | |||
N1 | 72 (78.3) | 49 (75.4) | 0.673 |
N2 | 20 (21.7) | 16 (24.6) | |
Adjuvant chemotherapy | |||
No | 19 (20.7) | 13 (20.0) | 0.920 |
Yes | 73 (79.3) | 52 (80.0) | |
Follow up, months | 68.0 (52.3–84.8) | 68.0 (53.5–84.5) | 0.531 |